Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (251-260 of 395) with videos related to

Pageof 40
Sort By:
Rheumatology International|July 3, 2019
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohortPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experimentMatteo Piga, Luca Quartuccio, Fabiola Atzeni, et al.
International Journal of Rheumatic Diseases|October 31, 2017
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registryEnnio G Favalli, Luigi Sinigaglia, Andrea Becciolini, et al.
Clinical and Experimental Rheumatology|June 10, 2025
Web search trends on fibromyalgia: development of a machine learning modelMatteo Luigi G Leoni, Marco Mercieri, Antonella Paladini, et al.
Journal of Clinical Medicine|March 6, 2021
The Rheumatology Drugs for COVID-19 Management: Which and When?Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez-Carrio, et al.
European Journal of Internal Medicine|November 5, 2024
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of RheumatologyFabio Cacciapaglia, Francesca Romana Spinelli, Gian Luca Erre, et al.
BMC Rheumatology|May 31, 2019
AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)Gary J Macfarlane, Ejaz Pathan, Stefan Siebert, et al.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Plos One|May 22, 2013
TLR-4 and VEGF polymorphisms in chronic periaortitisFabiola Atzeni, Luigi Boiardi, Augusto Vaglio, et al.
Journal of Clinical Medicine|March 29, 2023
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study GroupFabio Cacciapaglia, Francesca Romana Spinelli, Elena Bartoloni, et al.
Pageof 40

Showing results (251-260 of 395) with videos related to

Sort By:
Pageof 40
Rheumatology International|July 3, 2019
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohortPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experimentMatteo Piga, Luca Quartuccio, Fabiola Atzeni, et al.
International Journal of Rheumatic Diseases|October 31, 2017
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registryEnnio G Favalli, Luigi Sinigaglia, Andrea Becciolini, et al.
Clinical and Experimental Rheumatology|June 10, 2025
Web search trends on fibromyalgia: development of a machine learning modelMatteo Luigi G Leoni, Marco Mercieri, Antonella Paladini, et al.
Journal of Clinical Medicine|March 6, 2021
The Rheumatology Drugs for COVID-19 Management: Which and When?Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez-Carrio, et al.
European Journal of Internal Medicine|November 5, 2024
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of RheumatologyFabio Cacciapaglia, Francesca Romana Spinelli, Gian Luca Erre, et al.
BMC Rheumatology|May 31, 2019
AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)Gary J Macfarlane, Ejaz Pathan, Stefan Siebert, et al.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Plos One|May 22, 2013
TLR-4 and VEGF polymorphisms in chronic periaortitisFabiola Atzeni, Luigi Boiardi, Augusto Vaglio, et al.
Journal of Clinical Medicine|March 29, 2023
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study GroupFabio Cacciapaglia, Francesca Romana Spinelli, Elena Bartoloni, et al.
Pageof 40